Corcept Therapeutics Inc (CORT)
51.43
+0.28
(+0.55%)
USD |
NASDAQ |
Dec 20, 16:00
51.46
+0.03
(+0.06%)
After-Hours: 20:00
Corcept Therapeutics Market Cap: 5.389B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics Inc | 4.113B |
| Catalyst Pharmaceuticals Inc | 2.537B |
| Madrigal Pharmaceuticals Inc | 6.733B |
| Alnylam Pharmaceuticals Inc | 31.66B |
| Ionis Pharmaceuticals Inc | 5.627B |
Market Cap Related Metrics
| PE Ratio | 40.82 |
| PS Ratio | 9.117 |
| PEG Ratio | 0.7347 |
| Price to Book Value | 8.435 |
| Price to Free Cash Flow | 40.18 |
| Price | 51.43 |
| Earnings Yield | 2.45% |
| PEGY Ratio | 0.7347 |
| Operating PE Ratio | 39.97 |
| Normalized PE Ratio | 40.82 |